Basic Body Awareness Therapy for Healthy Young Adults
ConditionYoung Healthy Adults
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorÖzge ÇANKAYA
About this trial
Background:
Musculoskeletal pain, impaired postural control, and reduced movement quality are increasingly observed among young adults, partly due to sedentary lifestyles and insufficient physical activity. Basic Body Awareness Therapy (BBAT) is a physiotherapy-based mind-body approach designed to enhance body awareness, movement quality, balance, and postural stability through controlled functional movements. Although BBAT has demonstrated beneficial effects in various clinical populations, evidence regarding its effectiveness in healthy young adults remains limited.
Objective:This study aims to investigate the effects of a 12-week BBAT program on balance, musculoskeletal pain, spinal mobility, and flexibility in healthy young adults.
Methods:This randomized controlled trial will be conducted at the Healthy Living Laboratory of the University of Health Sciences, Gülhane Faculty of Physiotherapy and Rehabilitation, between June 2026 and May 2027. Healthy individuals aged 18-40 years will be recruited through voluntary participation and social media announcements. Participants will be randomly assigned to either a BBAT intervention group or a control group. The intervention group will participate in supervised BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes, while the control group will receive no intervention. Eligible participants will be individuals aged 18-40 years who have not participated in structured body-awareness-based exercise programs, such as BBAT, yoga, or Pilates, within the previous six months and who are able to complete all assessment procedures independently. Individuals with neurological, vestibular, rheumatological, or severe orthopedic disorders, recent surgery or injury affecting the spine or lower extremities, pregnancy, acute infection, or medication use affecting balance will be excluded.
Spinal mobility and flexibility will be the primary outcome measure. Secondary outcomes will include musculoskeletal pain and balance. Assessments will be performed before and after the intervention period.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age between 18 and 40 years.
Ability to walk independently without assistive devices.
No participation in structured body-awareness-based exercise programs (e.g., Basic Body Awareness Therapy, yoga, or Pilates) within the previous 6 months.
Ability to understand study procedures and comply with assessment protocols.
Disqualifiers
History of neurological, vestibular, rheumatologic, or severe orthopedic disorders that may affect movement, balance, or mobility.
History of spinal or lower-extremity surgery or musculoskeletal injury within the previous 6 months.
Severe musculoskeletal pain limiting participation in assessments or intervention sessions.
Pregnancy.
Trial design
Design model
Parallel
Treatments tested in this trial
Exercise
Other interventionParticipants allocated to the intervention group will receive a 12-week Basic Body Awareness Therapy (BBAT) program. The intervention will be delivered once weekly on the same day and at the same time each week, with each session lasting approximately 45-60 minutes. The BBAT program will consist of structured exercises performed in supine, sitting, and standing positions, focusing on postural alignment, muscle activation and relaxation, breathing awareness, weight transfer, balance control, and movement quality. Individual and partner-based exercises will be used to enhance body awareness, postural stability, and coordinated movement patterns. All sessions will be supervised and conducted by a physiotherapist who has completed BBAT Level III training. Participants will be encouraged to perform the movements with attention to body awareness, balance, breathing, and movement efficiency throughout the intervention period.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: ControlNo intervention 0 interventions
Group B: ExerciseExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Spinal mobility
Spinal mobility will be assessed using the Spinal Mouse® system (Idiag AG, Fehraltorf, Switzerland). Measurements will be obtained in neutral standing, maximal flexion, maximal extension, and maximal lateral flexion positions. Two measurements will be recorded for each position, and the average value will be used for analysis.
Time frame
Baseline and Week 122
Flexibility
Flexibility of the lumbar region and lower extremities will be evaluated using the Sit-and-Reach Test. Participants will perform three trials, and the best score (cm) will be recorded for analysis.
Time frame
Baseline and Week 12Secondary outcomes
1
Musculoskeletal pain
Musculoskeletal pain and discomfort will be assessed using the Cornell Musculoskeletal Discomfort Questionnaire (CMDQ). The CMDQ evaluates the frequency, severity, and functional impact of discomfort in different body regions. Total CMDQ scores will be used for analysis.
Time frame
Baseline and Week 122
Balance
Balance performance will be assessed using the HUR Balance® system. Static and dynamic postural control parameters, including center-of-pressure sway and stability measures, will be recorded according to the standardized testing protocol.
Time frame
Baseline and Week 12Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Özge ÇANKAYA
Lead sponsor
Hacettepe University
Sponsor institution
Saglik Bilimleri Universitesi
Collaborator
Source ClinicalTrials.gov